4//SEC Filing
Lux Venture Partners IV, LLC 4
Accession 0001209191-21-027701
CIK 0001601830other
Filed
Apr 19, 8:00 PM ET
Accepted
Apr 20, 9:30 PM ET
Size
28.3 KB
Accession
0001209191-21-027701
Insider Transaction Report
Form 4
Lux Co-Invest Opportunities, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2021-04-20−17,187,095→ 0 total(indirect: See footnote) - Conversion
Series A Preferred Stock
2021-04-20−10,279,275→ 0 total(indirect: See footnote)→ Common Stock (10,279,275 underlying) - Conversion
Series D Preferred Stock
2021-04-20−1,490,783→ 0 total(indirect: See footnote)→ Common Stock (1,490,783 underlying) - Purchase
Class A Common Stock
2021-04-16$18.00/sh+100,000$1,800,000→ 100,000 total(indirect: See footnote) - Conversion
Common Stock
2021-04-20+17,174,594→ 17,187,095 total(indirect: See footnote) - Conversion
Class A Common Stock
2021-04-20+17,187,095→ 17,287,095 total(indirect: See footnote) - Conversion
Series C Preferred Stock
2021-04-20−1,825,883→ 0 total(indirect: See footnote)→ Common Stock (1,825,883 underlying) - Conversion
Series B Preferred Stock
2021-04-20−3,578,653→ 0 total(indirect: See footnote)→ Common Stock (3,578,653 underlying)
Lux Co-Invest Partners, LLC
10% Owner
Transactions
- Conversion
Common Stock
2021-04-20−17,187,095→ 0 total(indirect: See footnote) - Purchase
Class A Common Stock
2021-04-16$18.00/sh+100,000$1,800,000→ 100,000 total(indirect: See footnote) - Conversion
Common Stock
2021-04-20+17,174,594→ 17,187,095 total(indirect: See footnote) - Conversion
Class A Common Stock
2021-04-20+17,187,095→ 17,287,095 total(indirect: See footnote) - Conversion
Series A Preferred Stock
2021-04-20−10,279,275→ 0 total(indirect: See footnote)→ Common Stock (10,279,275 underlying) - Conversion
Series B Preferred Stock
2021-04-20−3,578,653→ 0 total(indirect: See footnote)→ Common Stock (3,578,653 underlying) - Conversion
Series D Preferred Stock
2021-04-20−1,490,783→ 0 total(indirect: See footnote)→ Common Stock (1,490,783 underlying) - Conversion
Series C Preferred Stock
2021-04-20−1,825,883→ 0 total(indirect: See footnote)→ Common Stock (1,825,883 underlying)
Lux Venture Partners IV, LLC
10% Owner
Transactions
- Conversion
Common Stock
2021-04-20+17,174,594→ 17,187,095 total(indirect: See footnote) - Conversion
Common Stock
2021-04-20−17,187,095→ 0 total(indirect: See footnote) - Conversion
Class A Common Stock
2021-04-20+17,187,095→ 17,287,095 total(indirect: See footnote) - Conversion
Series B Preferred Stock
2021-04-20−3,578,653→ 0 total(indirect: See footnote)→ Common Stock (3,578,653 underlying) - Conversion
Series D Preferred Stock
2021-04-20−1,490,783→ 0 total(indirect: See footnote)→ Common Stock (1,490,783 underlying) - Conversion
Series A Preferred Stock
2021-04-20−10,279,275→ 0 total(indirect: See footnote)→ Common Stock (10,279,275 underlying) - Conversion
Series C Preferred Stock
2021-04-20−1,825,883→ 0 total(indirect: See footnote)→ Common Stock (1,825,883 underlying) - Purchase
Class A Common Stock
2021-04-16$18.00/sh+100,000$1,800,000→ 100,000 total(indirect: See footnote)
Lux Ventures IV, L.P.
10% Owner
Transactions
- Conversion
Series C Preferred Stock
2021-04-20−1,825,883→ 0 total(indirect: See footnote)→ Common Stock (1,825,883 underlying) - Conversion
Class A Common Stock
2021-04-20+17,187,095→ 17,287,095 total(indirect: See footnote) - Conversion
Series A Preferred Stock
2021-04-20−10,279,275→ 0 total(indirect: See footnote)→ Common Stock (10,279,275 underlying) - Conversion
Common Stock
2021-04-20+17,174,594→ 17,187,095 total(indirect: See footnote) - Conversion
Series B Preferred Stock
2021-04-20−3,578,653→ 0 total(indirect: See footnote)→ Common Stock (3,578,653 underlying) - Conversion
Series D Preferred Stock
2021-04-20−1,490,783→ 0 total(indirect: See footnote)→ Common Stock (1,490,783 underlying) - Purchase
Class A Common Stock
2021-04-16$18.00/sh+100,000$1,800,000→ 100,000 total(indirect: See footnote) - Conversion
Common Stock
2021-04-20−17,187,095→ 0 total(indirect: See footnote)
Footnotes (10)
- [F1]50,000 of these shares are held by Lux Co-Invest Opportunities, L.P. and 50,000 of these shares are held by Lux Ventures IV, L.P.
- [F10]Represents 298,156 shares held of record by Lux Ventures IV, L.P. and 1,192,627 shares held of record by Lux Co-Invest Opportunities, L.P.
- [F2]Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, LP and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, or the Individual Managers. The Individual Managers, as the sole managers of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P.
- [F3]Each of Lux Venture Partners IV, LLC, Lux Co-Invest Partners, LLC, and the Individual Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein.
- [F4]3,018,510 of these shares are held by Lux Co-Invest Opportunities, L.P. and 14,156,084 of these shares are held by Lux Ventures IV, L.P.
- [F5]Each share of Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock automatically converted into Class A Common Stock on a 1:1 basis immediately prior to the completion of Recursion Pharmaceuticals, Inc.'s (the "Issuer") initial public offering of Class A Common Stock (the "IPO"). Each shares of Series C Preferred Stock automatically converted into Class A Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's IPO. The right to convert Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock into Class A Common Stock had no expiration date.
- [F6]3,068,510 of these shares are held by Lux Co-Invest Opportunities, L.P. and 14,206,084 of these shares are held by Lux Ventures IV, L.P.
- [F7]Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's IPO.
- [F8]Represents shares held of record by Lux Ventures IV, L.P.
- [F9]Represents shares held of record by Lux Co-Invest Opportunities, L.P.
Documents
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
IncorporatedNY
Related Parties
1- filerCIK 0001633332
Filing Metadata
- Form type
- 4
- Filed
- Apr 19, 8:00 PM ET
- Accepted
- Apr 20, 9:30 PM ET
- Size
- 28.3 KB